ArticleBreast care (Basel, Switzerland)2016

Neoadjuvant Chemotherapy with Docetaxel, Carboplatin and Weekly Trastuzumab Is Active in HER2-Positive Early Breast Cancer: Results after a Median Follow-Up of over 4 Years.

Hans-Christian Kolberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.